PAPINESCHI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 6.641
AS - Asia 2.873
EU - Europa 2.412
SA - Sud America 398
AF - Africa 179
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 12.508
Nazione #
US - Stati Uniti d'America 6.457
CN - Cina 904
IT - Italia 862
SG - Singapore 811
HK - Hong Kong 452
SE - Svezia 416
BR - Brasile 334
VN - Vietnam 246
BG - Bulgaria 234
DE - Germania 183
TR - Turchia 163
CA - Canada 153
UA - Ucraina 149
GB - Regno Unito 121
FI - Finlandia 114
CI - Costa d'Avorio 108
RU - Federazione Russa 107
FR - Francia 89
KR - Corea 77
CH - Svizzera 60
IN - India 56
JP - Giappone 52
NG - Nigeria 23
IQ - Iraq 22
BD - Bangladesh 21
BE - Belgio 19
MX - Messico 18
AR - Argentina 15
SN - Senegal 14
EC - Ecuador 10
ID - Indonesia 9
SA - Arabia Saudita 9
ES - Italia 8
NL - Olanda 8
VE - Venezuela 8
CL - Cile 7
CO - Colombia 7
PH - Filippine 7
PK - Pakistan 7
PY - Paraguay 7
TN - Tunisia 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
IE - Irlanda 6
KE - Kenya 6
AT - Austria 5
BJ - Benin 5
PL - Polonia 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
JO - Giordania 4
RO - Romania 4
CZ - Repubblica Ceca 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
IL - Israele 3
PE - Perù 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
DK - Danimarca 2
EU - Europa 2
JM - Giamaica 2
LB - Libano 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.508
Città #
Woodbridge 768
Houston 563
Ann Arbor 539
Ashburn 531
Singapore 478
Fairfield 459
Hong Kong 447
Chandler 434
Santa Clara 429
Serra 282
Milan 262
Dallas 249
San Jose 245
Sofia 234
Jacksonville 203
Seattle 202
Shanghai 193
Beijing 177
Wilmington 162
Cambridge 141
Ottawa 134
Izmir 125
New York 116
Abidjan 108
Princeton 102
Hefei 99
Boardman 92
Lawrence 83
Medford 78
Seoul 77
Nanjing 76
Lauterbourg 75
Los Angeles 66
Bern 59
Ho Chi Minh City 53
Dearborn 49
Nanchang 41
Rome 41
Tokyo 41
Council Bluffs 40
Des Moines 39
Hanoi 39
Jüchen 37
Buffalo 34
Florence 34
Redwood City 32
Istanbul 31
São Paulo 27
Dong Ket 25
Bremen 24
Helsinki 24
Kunming 24
San Diego 23
Lagos 22
Pune 21
Shenyang 20
Brussels 19
London 19
Redondo Beach 19
The Dalles 18
Boulder 17
Orem 17
Lancaster 16
Columbus 15
Munich 15
Dakar 14
Hebei 14
Rio de Janeiro 14
Changsha 13
Belo Horizonte 11
Jiaxing 11
Norwalk 11
Pisa 10
Chennai 9
Porto Alegre 9
Quanzhou 9
Westminster 9
Baghdad 8
Curitiba 8
Da Nang 8
Frankfurt am Main 8
Haiphong 8
Hangzhou 8
Ogden 8
Washington 8
Auburn Hills 7
Tianjin 7
Guayaquil 6
Sorocaba 6
Tashkent 6
Atlanta 5
Changchun 5
Charlotte 5
Costa Mesa 5
Cotonou 5
Denver 5
Dublin 5
Fuzhou 5
Goiânia 5
Jinan 5
Totale 9.444
Nome #
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen. Leuk Lymphoma 238
Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly. 227
Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing Camelia Sinensis leaf extract 219
CHEMOIMMUNOTHERAPY REGIMEN OF FLUDARABINE, CYCLOPHOSPHAMIDE, AND RITUXIMAB FOLLOWED BY ALEMTUZUM- AB AS INITIAL THERAPY FOR CHRONIC LYMPHOCYTIC LEUKAEMIA: A VALID APPROACH FOR ERADICATION OF MINIMAL RESIDUAL DISEASE 216
Infliximab treatment of grade IV skin acute graft versus host disease 215
Alteraciones funcionales de los granulocitos neutrofilos en un joven neutropenico de raza negra 208
EFFICACY OF FLUDARABINE, CYCLOPHOSPHAMIDE, RITUXIMAB (FCR) REGIMEN FOL- LOWED BY ALEMTUZUMAB AS IN VIVO PURGING TOOL FOR PATIENTS WITH ADVANCED CHRONIC LYMPHOCYTIC LEUKEMIA 207
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia. 205
Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen 202
Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 201
Case of erythema elevatum diutinum associated with IgA paraproteinemia successfully controlled with thalidomide and plasma exchange 197
Skin and stomach graft versus host disease after syngeneic BMT in CML: A case report., LEUKEMIA RESEARCH,pp 00,tot.pag 00,tot. autori 7,2007 190
Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: a report in a case of delayed graft failure 189
Early Diagnosis of Neutropenic Enterocolitis by Ultrasound Sonography. 180
Aggressive Non Hodgkin lymphoma'patients Treated by High Dose Chemotherapy and Immunotherapy Has a Lower Relapse Rate: Results of a Computer Science Analysis. 176
Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: A prospective, randomized study with a mouthwash containing Camelia Sinensis leaf extract 168
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life 164
Chronic lymphocytic leukemia (B-cell) in the course of polycythemia vera. Description of a case with an unusual chromosomic anomaly. 164
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) 161
[Functional changes in polymorphonuclear neutrophils in a neutropenic young Negro]. 160
Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation ofits biological effects on the hematopoietic neoplastic clone. Italian Cooperative Group on Essentyal Thrombocytemia 158
Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography 158
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 157
AUTOLOGOUS STEM CELL TRANSPLANTATION IMPROVE OUTCOME IN NON-HODGKIN'S LYMPHOMA: RESULTS OF A COMPUTER SCIENCE ANALYSIS. 157
Functional immune reconstitution after high-dose chemotherapy parallels control of endogenous viral reactivation: the torquetenovirus model 156
IN VIVO PURGING WITH HYPER-CAVD PLUS RITUXIMAB FOLLOWED BY AUTOLOGOUS TRANSPLANTATION AND RITUXIMAB MAINTENANCE IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA. 155
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in ch 154
QUALITATIVE AND QUANTITATIVE MOLECULAR EVALUATION OF MRD IN INDOLENT NHL TREATED WITH HIGH-DOSE THERAPY AND RITUXIMAB. 151
Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia. 151
IN VIVO PURGING WITH HYPER-CVAD PLUS RITUXIMAB IN NEWLY DIAGNOSED MANTLE CELL LYMPHOMA. 150
Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature 150
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by Rituximab 149
A myeloablative allograft after rejection of two consecutive nonmyeloablative transplants from two different HLA identical siblings 149
PERITRANSPLANT SITAGLIPTIN MODIFIES SERUM SDF-1ALPHA LEVELS IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION 149
Fatal ongoing human cytomegalovirus reactivation during high-dose melphalan and autologous stem cell transplantation. 148
CONTRAST ENHANCED UNLTRASOUND SONOGRAPHY IN INTESTINAL ACUTE GRAFT-VERSUS-HOST DISEASE. 146
rhG-CSF-induced phenotypic changes of neutrophils from patients undergoing autologous PBSC transtantation 145
Autologous transplantation with Philadelphia chromosome negative stem cells mobilized in first chronic phase-chronic myeloid leukaemia 145
GAMMA-DELTA T-LYMPHOCYTE SPECIFIC CLONES ARE INVOLVED IN THE GRAFT-VERSUS-MYELOMA AND IN THE GRAFT-VERSUS-HOST DISEASE IN MULTIPLE MYELOMA PATIENTS AFTER NON-MYELOABLATIVE TRANSPLANTATION. 144
Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literature. 144
Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: clinical response after plasma exchange. 144
Hyperbaric oxygen therapy in a case of post-total body irradiation colytis, 143
Contrast Enhanced Ultrasound Sonography in Intestinal Acute Graft Versus Host Disease: Advantages of Non-Invasive Anatomic and Physiologic Measurements. 142
CONTRAST ENHANCED ULTRASOUND SONOGRAPHY IN INTESTINAL ACUTE GRAFT VERSUS HOST DISEASE 142
Linezolid treatment for gram-positive infections: a retrospective comparison with teicoplanin 142
hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria long -term results of a retrospective study on behalf of the gruppo Italiano Trapianto Osseo (GITMO) 141
Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications 141
Plicamycin-hydroxyurea association in chronic granulocytic leukemia and multidrug resistance. 140
NEUTROPENIC ENTEROCOLITIS: USEFULNESS OF ULTRASOUND SONOGRAPHY. SINGLE-CENTER EXPERIENCE 140
Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation 140
Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy. 140
The Role of Imaging in Relapse Detection During Follow up: a Fifteen-Year Single Center Experience. 139
Optimizing Follow up Schedule for Non Hodgkin Lymphoma' Patients by Multi-Objective Analysis. 139
Alpha-2a-interferon administration and Fc gamma RIII expression on neutrophils from chronic myeloid leukemia 139
Adjunctive chromosomal abnormalities in Philadelphia-negative cells of CML patients treated with Imatinib 138
Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature 137
Ultrasound findings guided a successful hemicolectomy in a leukemic patient with neutropenic enterocolitis 137
Recombinant 2a Interferon and Polycythemia Vera: clinical results and biological evaluation by means of Fourier-Transform Infrared Microspectroscopy 136
ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION FOLLOWING A NON-MYELOABLATIVE (NMST) CONDITIONING WITH FLUDARABINE AND LOW DOSE TBI IN PATIENTS WITH HEMATOLOCICAL MALIGNANCIES AND METASTATIC MELANOMA: A SINGLE-CENTER EXPERIENCE. 135
False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma 134
Arsenic and all-trans acid as induction theraphy autograft in a case of relapsed resistant secondary acute promyelocytic leukaemia 132
Simultaneous appearance of acute myeloid leukemia in a patient with bilateral primary uveal melanoma 131
Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. 131
The role of molecular monitoring in autotransplantation for non-Hodgkin's lymphoma 130
Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia 129
FcRIII (CD16) expression on neutrophils from chronic myeloid leukemia. A flow cytometric study 128
Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation 128
Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study 127
Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: a report in a case of delayed graft failure 127
Preemptive valganciclovir for cytomegalovirus infection in hematological patients 126
Consolidation therapy with idarubicin, cisplatin and prednisone (CIP) after P-Vabec regimen in the treatment of intermediate and high grade non Hodgkin’s lymphomas in the eldery 125
Complex translocation t(6;9;22)(p21.1;q34;q11) at diagnosis is a therapy resistance index in chronic myeloid leukaemia. 125
Renal carcinoma in two patients with poor prognosis NHL treated with high-dose chemotherapy and peripheral stem cell autotransplantation 124
Central nervous system graft-versus-host disease: consider progressive multifocal leukoencephalopathy among the differential diagnoses 124
Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report 123
Neutrophil functions in chronic myeloid leukemia 120
Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractoty to intravenous and intravesical cidofovir:Case report and review of literature 115
Phenobarbital-associated bone marrow aplasia: a case report and review of the literature 111
In Vivo Purging with Hyper-CVAD Plus Rituximab Followed by Autologous Stem Cells Transplant and Rituximab Maintenance in Newly Diagnosed Mantle Cell Lymphoma: A Pilot Study for GISL (Italian Cooperative Study Group for Lymphoma). 111
Gentuzumab ozogamicin plus Flang (My-Flang) in refractory/relapsed acute myeloid leukaemias patients and pre-allogenic stem cell transplant 110
Changes In CD8+57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremia 109
Granulocytic sarcoma and subsequent acute leukemia recurrence with different biologic characteristics 5 years after allogeneic bone marrow transplantation for acute myeloid leukemia 100
Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agent. 71
Prospective qualitative and quantitative non-invasive evaluation of intestinal acute GVHD by contrast-enhanced ultrasound sonography 63
null 58
Totale 12.570
Categoria #
all - tutte 33.935
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.935


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022920 20 62 26 69 178 132 21 46 31 18 53 264
2022/20231.278 150 140 89 133 127 166 3 99 287 6 67 11
2023/2024829 145 130 113 66 121 135 12 14 11 4 7 71
2024/20252.353 7 98 14 122 271 267 192 126 221 324 266 445
2025/20262.198 94 372 277 155 212 281 317 94 125 164 85 22
2026/202723 23 0 0 0 0 0 0 0 0 0 0 0
Totale 12.570